001     119707
005     20240228134951.0
024 7 _ |a 10.1016/j.acra.2014.04.011
|2 doi
024 7 _ |a pmid:24998693
|2 pmid
024 7 _ |a 1076-6332
|2 ISSN
024 7 _ |a 1878-4046
|2 ISSN
037 _ _ |a DKFZ-2017-00334
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Bretschi, Maren
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a Assessing treatment response of osteolytic lesions by manual volumetry, automatic segmentation, and RECIST in experimental bone metastases.
260 _ _ |a Philadelphia, PA [u.a.]
|c 2014
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1488877432_30484
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Aim of the study was to compare between volumetric and unidimensional approaches for treatment response monitoring in a nude rat model of experimental bone metastases. For the volumetric approach, an automated segmentation algorithm of osteolytic lesions was introduced and compared to manual volumetry.Nude rats bearing osteolytic metastases were treated with zoledronate and sunitinib and compared to controls. Treatment response was assessed longitudinally in vivo using flat-panel volumetric computed tomography at days 30, 35, 45, and 55 after tumor cell inoculation. The mean sizes and volumes of osteolytic lesions were determined according to response evaluation criteria in solid tumors (RECIST) and by automated and manual volumetry (software: MITK [The Medical Imaging Interaction Toolkit, Heidelberg, Germany] and VIRTUOS, Heidelberg, Germany).In contrary to RECIST, the manual volumetric approach indicated a significant decrease in osteolytic lesion volume in response to treatment. The presented automatic segmentation algorithm for treatment monitoring identified bone metastases adequately and assessed changes in the osteolytic lesion volume over time according to manual volumetry.In an animal model, volumetric treatment response assessment of osteolytic bone metastases is superior to unidimensional measurements, and automated volumetric segmentation may be a valuable alternative to manual volume determination.
536 _ _ |a 315 - Imaging and radiooncology (POF3-315)
|0 G:(DE-HGF)POF3-315
|c POF3-315
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Antineoplastic Agents
|2 NLM Chemicals
650 _ 7 |a Bone Density Conservation Agents
|2 NLM Chemicals
650 _ 7 |a Diphosphonates
|2 NLM Chemicals
650 _ 7 |a Imidazoles
|2 NLM Chemicals
650 _ 7 |a Indoles
|2 NLM Chemicals
650 _ 7 |a Pyrroles
|2 NLM Chemicals
650 _ 7 |a zoledronic acid
|0 6XC1PAD3KF
|2 NLM Chemicals
650 _ 7 |a sunitinib
|0 V99T50803M
|2 NLM Chemicals
700 1 _ |a Fränzle, Andrea
|0 P:(DE-He78)b51b8af8fb3459cf38fa735dc4f54e52
|b 1
|u dkfz
700 1 _ |a Merz, Maximilian
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Hillengass, Jens
|0 P:(DE-He78)7ccc574e713526d2a22d7acb9b2248c5
|b 3
|u dkfz
700 1 _ |a Semmler, Wolfhard
|0 P:(DE-He78)8354679bf4f1b32938e4abbac66bbd9b
|b 4
|u dkfz
700 1 _ |a Bendl, Rolf
|0 P:(DE-He78)4e7bb332499544552cf19660bec6f04f
|b 5
|u dkfz
700 1 _ |a Bäuerle, Tobias
|0 P:(DE-HGF)0
|b 6
|e Last author
773 _ _ |a 10.1016/j.acra.2014.04.011
|g Vol. 21, no. 9, p. 1177 - 1184
|0 PERI:(DE-600)2050425-1
|n 9
|p 1177 - 1184
|t Academic radiology
|v 21
|y 2014
|x 1076-6332
909 C O |o oai:inrepo02.dkfz.de:119707
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)b51b8af8fb3459cf38fa735dc4f54e52
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)7ccc574e713526d2a22d7acb9b2248c5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)8354679bf4f1b32938e4abbac66bbd9b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)4e7bb332499544552cf19660bec6f04f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-315
|2 G:(DE-HGF)POF3-300
|v Imaging and radiooncology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2014
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ACAD RADIOL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)E020-20160331
|k E020
|l Medizinische Physik in der Radiologie
|x 0
920 1 _ |0 I:(DE-He78)E040-20160331
|k E040
|l Medizinische Physik in der Strahlentherapie
|x 1
920 1 _ |0 I:(DE-He78)E013-20160331
|k E013
|l Hämatoonkologische Bildgebung
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)E020-20160331
980 _ _ |a I:(DE-He78)E040-20160331
980 _ _ |a I:(DE-He78)E013-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21